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Abstract  
Documented reports of gastrointestinal stromal tumors (GIST) are relatively few in the sub-Saharan continent. The body of evidence points 
towards anal wall involvement being a rarity indeed. In this article we document a 61 year old Nigerian man who presented with bleeding per 
rectum and in whom the histological features (including immunohistochemistry) of the biopsied anal lesion was GIST. 
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Mazur and Clark were the first to coin the term “Gastrointestinal 
stromal tumors (GISTs)” in 1983 [1]. The pair of scientists 
characterized this group of tumors at the subcellular and molecular 
levels in detail and is so doing were able to demonstrate that GISTs 
are distinct entities from leiomyomas and leiomyosarcomas - the 
group that they had, hitherto, been lumped into. Overall, they are 
still relatively uncommon findings as they represent a mere 0.3 to 1 
% of gastrointestinal neoplasms [2]. The incidence of these 
relatively rare tumors is rising as more mesenchymal tumors are 
now being tested for the C-Kit protein (CD117) which is one of the 
characteristic immunological markers that these lesions express [3]. 
Immunohistochemistry is relatively unavailable in resource-limited 
countries like Nigeria. The absence of this vital tool for definitive 
diagnosis of GIST tumors has called into question many-a locally 
diagnosed “GIST” tumor as aptly demonstrated by Ezeome et al [4]. 
Two thirds of GISTs occur in the stomach while the small intestine 
GISTs account for two third of the others [2]. The rarity of anal wall 
site is well documented as only a handful has been reported [5]. 
This article seeks to document what, to the best of our knowledge, 
would be the first such immunohistochemically proven case of GIST 
of the anal wall from our region.  
  
  
Patient and observation 
 
A 61 year old Nigerian gentleman was referred for colonoscopy in 
Lagos, Nigeria on account of passage of blood per rectum. The 
patient had noted the initial episode about 3 months prior to 
presentation. The blood was noted to precede and also line the 
periphery of the fecal bulk that was expelled. There was no history 
of alteration in bowel habit nor did the patient report any other 
systemic symptoms. The patient was in stable clinical condition on 
examination and the digital rectal examination had revealed a small, 
soft mass in the anterior aspect of the anal wall with the withdrawn 
finger being stained with blood. A packed cell volume test was 41%. 
Upon retroflexion in the rectum, the colonoscopy findings were that 
of a 5 cm in diameter polypoidal mass in the anterior wall of the 
anal canal. The mass had multiple umbilications on its irregular 
surface and was noted to be gently oozing blood at the time of 
examination. Cold forceps were used to biopsy the lesion and 
samples were sent for histology. The clinical suspicion of a 
malignant tumour was raised. An abdominal computed tomography 
(CT) scan revealed a small mass in the anal wall with focal mural 
thickening and minimal fat stranding which is indicative of limited 
local infiltration. There was no radiographic suggestion of regional 
lymph node involvement. The microscopic examination showed 
complete replacement of the tissue by a focally necrotic tumor that 
comprised proliferating stromal cells with peripheral palisading 
(Figure 1). Nuclear atypia was absent and mitotic count was 5 per 
10 high Power fields. The immunohistochemical stain patterns 
showed strong positivity for C-kit (CD 117), moderate positivity for 
smooth muscle antigen (SMA) and weak positivity for CD 34. Other 
immunohistochemical staining patterns reveal Ki-67 (6-8 %) while 
protein S-100 and Pan CK were negative (Figure 2, Figure 3, 
Figure 4). The combination of the two modalities confirmed the 
absence of carcinoma and the strong positivity for CD 117 indicated 
the lesion was a GIST. Upon review of the results, the findings were 
communicated to the referring physician and the patient was then 
sent to a Gastroenterologist closer to his base. The patient is said to 






The above case report details a rare case of GIST of the anal wall in 
an elderly Nigerian patient. The case, with its full 
immunohistochemical characterization, to the best of the authors' 
knowledge, is the first of such from this region of Africa. The 
occurrence of anal GIST is very rare indeed as it represents only 3% 
of ano-rectal mesenchymal tumors [6]. Put in perspective, GISTs 
only occur in this region in 5% of cases [7]. In fact, a 2007 review 
found only ten cases of c-kit positive anal GIST in the scientific 
literature [8]. GIST is not a new entity to this part of the world as 
several local case reports and series have examined various aspects 
of the tumor [4]. Immunohistochemistry has been noted to be 
crucial for definitive diagnosis but this important component has not 
always featured in many-a-locally made diagnosis [4,9,10]. The 
obvious reason for this is that the modality is not readily available in 
our environment [4,11]. The case here presented highlights this 
area of need in gastroenterology in this locality as the 
immunohistochemistry was done in a foreign center. Prognostic 
indices have been well characterized in GIST and include the size of 
the tumor, the mitotic index of the lesion, as well as some as yet 
undefined malignant factors as acknowledged in the 2002 
consensus guidelines [3]. These undetermined factors have also 
instructed the wordings of the guidelines to highlight that GIST is 
categorized in risk groups, further emphasizing that no lesion is 
definitely labeled as “benign” [3]. The therapeutic approach in this 
case is interesting. The surgical team decided to progress to 
abdominoperineal resection as the pre-surgical CT scan was positive 
for local infiltration though negative for regional lymph node 
involvement. His advanced age notwithstanding, the decision for 
surgery was made as the risks of GIST-related morbidity (and 
possible mortality) with only excision was unacceptable. This was in 
keeping with sound scientific opinion from literature [8]. The role of 
tyrose kinase inhibitors, imatinib in this case, is still controversial. 
But the surgical team planned to administer this to the patient for at 
least one year and continue lifelong monitoring in view of possibility 
of recurrences or metastases [6]. The first year post follow up 
screens done at the patient's base (CT scan and colonoscopy with 





The report documents a rare case of anal GIST as a cause of 
hematochezia in a patient from sub-Saharan Africa. The need for 
advanced histopathologic assessment (including detailed 
immunohistochemitry) of all such lesions to provide further clarity 
after basic histology stains is further emphasized- even as we note 
that the resource constrained environment that we live in makes 
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Figure 1: Low power photomicrograph of the anal lesion. It shows 
the necrotic tumor comprising of proliferating stromal cells with 
peripheral palisading (Hematoxylin and Eosin stain; original 
magnification × 40)  
Figure 2: (A): Immunohistochemical stain patterns showing strong 
positivity for c-kit; (B): and moderate positivity for SMA (original 
magnification × 40)  
Figure 3: (A): Immunohistochemical stain patterns showing 
negativity for Pan CK; (B): and protein S 100 (original magnification 
× 40)  
Figure 4: Immunohistochemistry for Ki-67 showing some nuclear 
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Figure 1: Low power photomicrograph of the anal lesion. It shows the necrotic 
tumor comprising of proliferating stromal cells with peripheral palisading 
(Hematoxylin and Eosin stain; original magnification × 40)  
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Figure 2: (A): Immunohistochemical stain patterns showing strong positivity for 




Figure 3: (A): Immunohistochemical stain patterns showing negativity for Pan 




Figure 4: Immunohistochemistry for Ki-67 showing some nuclear positivity 
(original magnification × 40) 
 
 
 
